JPRN-UMIN000012273
Not yet recruiting
未知
A multicenter clinical study to test the efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism. - A multicenter clinical study to test the efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism.
Department of Obstetrics and Gynecology, Mie university hospital.0 sites5 target enrollmentNovember 12, 2013
Conditionsclinical amnitotic fluid embolism
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- clinical amnitotic fluid embolism
- Sponsor
- Department of Obstetrics and Gynecology, Mie university hospital.
- Enrollment
- 5
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are anaphylactic to C1\-inhibitor drug.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Home-based and group cognitive intervention programs in amnestic mild cognitive impairmentMental and behavioral disordersKCT0000328Inha University Hospital270
Not yet recruiting
Not Applicable
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
Not yet recruiting
Not Applicable
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive ImpairmentMental and behavioural disordersKCT0007184Inha University Hospital100
Not yet recruiting
Phase 2
ACENT 1Patients with Sickle Cell Disease.Sickle cell disease (SCD) Foetal haemoglobin (HbF) mutated sickle cell haemoglobin (HbS)LBCTR2024015480ovo Nordisk87
Completed
Phase 2
Research study investigating how well NDec works in people with sickle cell disease2023-508506-22-00Novo Nordisk A/S15